• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow
Is it Possible to Create an Ethical Psychedelics Company?

Is it Possible to Create an Ethical Psychedelics Company?

by EmpathiCSubstanceS | Nov 9, 2021 | Cancer, CBC, Cluster Headaches, Depression, MDMA Sassafras Molly, Neuropathy, NN-Dimethyltryptamine

At a virtual investment conference last week called Psychedelic Capital, the moderator of a session on ethical intellectual property opened the panel by asking, “To patent or not patent? That is the question.” That certainly is the question that’s been hotly debated...
Is it Possible to Create an Ethical Psychedelics Company?

Do Psychedelics Just Provide Comforting Delusions?

by EmpathiCSubstanceS | Nov 8, 2021 | Addiction, Alcoholism, Ayahuasca, Cancer, Cluster Headaches, Depression, Iboga, Kambo, Parkinson's Disease, Psychotropics

And if so, does it matter? In a new book, philosopher Chris Letheby confronts the nature and implications of the mystical experiences people often have while taking psychedelics. There’s an “elephant in the room” of psychedelic science, according to an opinion...
Is it Possible to Create an Ethical Psychedelics Company?

Can a Psychedelic Experience Improve Your Life?

by EmpathiCSubstanceS | Nov 8, 2021 | Ayahuasca, Cancer, Cluster Headaches, Iboga, Kambo, MDMA Sassafras Molly

My earliest exposure to psychedelics came from growing up near the Haight Ashbury in San Francisco, well past the glory days of the Summer of Love. The Haight Street of my youth was a tourist destination for hippiesque consumerism, not a countercultural hub, though I...
Is it Possible to Create an Ethical Psychedelics Company?

Why is Psilocin Orally Active?

by EmpathiCSubstanceS | Nov 8, 2021 | Alcoholism, Ayahuasca, Cancer, CBC, Cluster Headaches, DMT, LSD, Neuropathy, OCD, Parkinson's Disease, Psilocybin Magic Mushroom

This is the third article in a series on psychedelic chemistry, and the final article focusing on the tryptamine class. In the previous article we learned that though DMT and 5-MeO-DMT lack oral activity, chemistry wizards are able to change that. By making one of a...
Is it Possible to Create an Ethical Psychedelics Company?

What is Psychedelic Therapy?

by EmpathiCSubstanceS | Nov 8, 2021 | Alcoholism, Ayahuasca, Cancer, Cluster Headaches, DMT, LSD, Neuropathy, OCD, Psilocybin Magic Mushroom, Psychotropics, San Pedro Mescaline

Common Trends, Practices, and Foundations in the Field. Now that millions of dollars are being invested in psychedelics and platforms ranging from Fox News to Bloomberg are reporting positively on them, it’s safe to say that psychedelic therapy has entered the...
Is it Possible to Create an Ethical Psychedelics Company?

Can Psychedelics Provide Relief for Autistic Individuals?

by EmpathiCSubstanceS | Nov 8, 2021 | Ayahuasca, Cancer, CBC, Chronic Pain, Cluster Headaches, Microdosing, Neuropathy

What Is Transpersonal Psychology? Sometimes transpersonal psychology is referred to as “spiritual psychology” or “the psychology of spirituality” in that it is the branch of psychology that concerns itself with the domain of human experience that is not limited to...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

Aug 17, 2022

PY dose dependently increased scores of all 5D-ASC core dimensions. Only one subject reacted with transient anxiety to HD PY. Compared with PL, MD and HD PY led to a 50% reduction of performance in the FAIR test. "General inactivation", "emotional excitability", and...

Altered trajectories in the dynamical repertoire of functional network states under psilocybin

Aug 17, 2022

We found that a FC state closely corresponding to the fronto-parietal control system was strongly destabilized in the psychedelic state, while transitions toward a globally synchronized FC state were enhanced. These differences between brain state trajectories in...

Neuroticism is associated with challenging experiences with psilocybin mushrooms

Aug 17, 2022

CEQ scores were negatively associated with emotional stability scores (the inverse of neuroticism) in Study 1 and positively associated with neuroticism scores in Study 2. Neuroticism may contribute to the strength of challenging experiences with psychedelics in...

Psychedelic Medicine

Psychedelic Use Statistics

Sep 2, 2023

With scientific progress marching on and psychedelic use among adults exploding, the need for creating infrastructure and delivering safe and legal access is already upon us. Recently published data from the annual Monitoring the Future (MTF) survey by the National...

Neuroplasticity Explained

Sep 2, 2023

A quarter of the world’s population is estimated to be affected by mental health or neurological challenges in their lifetime. In 2014, approximately 20% of U.S. adults had a mental illness and 22.5 million Americans aged 12 or older were in need of treatment for...

Mental Health Treatment Options

Sep 2, 2023

A quarter of the world’s population is estimated to be affected by mental health or neurological challenges in their lifetime. In 2014, approximately 20% of U.S. adults had a mental illness and 22.5 million Americans aged 12 or older were in need of treatment for...

Improving the End of Life Experience with Entheogens

Sep 2, 2023

:::In a 2019 study, 55% of families felt their loved one had a “bad death.” By igniting a movement to spark conversations and ask the right questions, we create opportunities for the things people most want – including spending time with those they love, dignity, and...

Veterans’ Psychedelic-Assisted Therapy

Sep 2, 2023

Psychedelic-Assisted Therapy is “a form of treatment that uses a group of substances that temporarily alter perception and mood and may impact numerous cognitive processes.” (Source: Evidence Brief: Psychedelic Medications for Mental Health and Substance Use...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow